SEC Form 4 · accession 0001213900-16-009911
RELMADA THERAPEUTICS, INC. · RLMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shreeram Agharkar
Director
Period of report
Dec 31, 2015
Accepted (ET)
Jan 5, 2016 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001553643
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Dec 31, 2015 | P | 400 | $2.50 | A | 5,759 | D |
Table II — derivative securities
No Table II lines on this filing.